Riskpilot← Back to searchSign inGet full accessTauron Diagnostics Oy Ltd
OYDissolvedY-tunnus 2869209-6Puistokaari 15-A6Other human health activities n.e.c. · NACE 8699Est. 2017— employees
Revenue 2025
EUR 0
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2025
EUR 0
| Revenue | EUR 0 | — |
| EBITDA | EUR 0 | — |
| Net profit | EUR 0 | — |
| Total assets | EUR 0 | — |
| Equity | EUR -502 | +0% |
| Employees | — | — |
Legal name
Tauron Diagnostics Oy Ltd
Y-tunnus number
2869209-6
Legal form
Osakeyhtiö
NACE code
8699 · Other human health activities n.e.c.
Founded
14. marraskuuta 2017
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on Lääketieteellinen diagnostiikan, biokemian ja kemian tutkimustyö ja tuotekehitys sekä kaikki näihin liittyvät työt. Yhtiö tekee myös edellisiin liittyvää tuotekauppaa. Yhtiön toimialaan kuuluu myös arvopapereiden ja kiinteistöjen osto, myynti sekä hallinta.
Address
Puistokaari 15-A6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | 0 | 0 | 0 | 0 |
| Staff expenses | — | −0 | −0 | −0 | −0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 |
| Depreciation & amort. | — | −0 | −0 | −0 | −0 |
| EBIT | 0 | 0 | 0 | 0 | 0 |
| Net financials | — | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 0 | 0 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 0 | 0 | 0 | 0 | 0 |
| Equity | −1 | −1 | −1 | −1 | −1 |
| Long-term debt | — | 0 | 0 | 0 | 0 |
| Short-term debt | 1 | 1 | 1 | 1 | 1 |
| Total debt | 1 | 1 | 1 | 1 | 1 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20212025
Equity ratio
-50200.0%
This company
38.2%
Market median
-131514% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JH Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairperson | 2022 | |
| Board of Directors | 2017 | |
| Former (1) | ||
| Chairperson | 2017 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tauron Diagnostics Oy Ltd also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jaakko Heikki Albert Levón | Chief Executive Officer | 0 companies |
| Kalle Martti Juhani Levon | Chairperson | 0 companies |
| Markus Samuli Wikstén | Board of Directors | 0 companies |
| Ron Michael Liebkind | Chairperson | 0 companies |